Aquilur Rahman , PhD President and Chief Executive Officer

Dr. Aquilur Rahman is one of the founders of NeoPharm Inc., and currently serves as the Company's President and Chief Executive Officer. After helping to take NeoPharm public in 1996, he served as the Chief Scientific Officer and a member of the Board of Directors from 1990 until 2001. Since that time he has served as an Adjunct Professor in the Department of Radiation Medicine at Georgetown University. In 2007, Dr. Rahman returned to NeoPharm and has since played a key role as an advisor for its research and development activities. Dr. Rahman has more than 20 years of research experience in developing new modalities of treatment for cancer patients. He holds 15 patents, has been an author of over a hundred peer reviewed publications and has been a speaker at numerous seminars and lectures. He received his Masters of Science in Biochemistry from the University of Dacca (Bangladesh) in 1964 and his Ph.D. in Pharmaceutics from the University of Strathclyde (Glasgow, U.K.) in 1972.

Shahid Ali, PhD Executive Vice President, Research & Development

Dr. Ali joined NeoPharm in January 2001, as Associate Director of Research and Development, and assumed the position of Executive Vice President, Research and Development in September 2007. Since joining the Company, Dr. Ali has held positions of increasing responsibility in Research and Development. Previously, Dr. Ali was a Group Leader at EpiGenesis Pharmaceuticals Inc. where he directed pre-clinical program for antisense oligonucleotide based therapeutic intervention in pulmonary diseases including bronchial asthma. Prior to EpiGenesis, Dr. Ali spent 10 years at the School of Medicine, East Carolina University, most recently serving as an Associate Research Professor in the departments of Medicine/Pharmacology. Dr. Ali received his M.S and Ph.D degrees from Lucknow University, Lucknow, India.